Paper41300545
Beyond Weight Loss: Optimizing GLP-1 Receptor Agonist Use in Children.
Zaitoon H and 3 others. Children (Basel), 2025. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Beyond Weight Loss: Optimizing GLP-1 Receptor Agonist Use in Children. Papers, record 41300545. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41300545
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References87
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32581001 | Flualprazolam: Report of an Outbreak of a New Psychoactive Substance in Adolescents. | Pediatrics | 2020 | https://conductscience.org/library/papers/32581001 | PubMed |
| 2 | 39065679 | Comparative Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity or Overweight: A Systematic Review and Network Meta-Analysis. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/39065679 | PubMed |
| 3 | 35658022 | Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes. | N Engl J Med | 2022 | https://conductscience.org/library/papers/35658022 | PubMed |
| 4 | 32635439 | Is BMI a Valid Indicator of Overweight and Obesity for Adolescents? | Int J Environ Res Public Health | 2020 | https://conductscience.org/library/papers/32635439 | PubMed |
| 5 | 37366315 | Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial. | N Engl J Med | 2023 | https://conductscience.org/library/papers/37366315 | PubMed |
| 6 | 40588554 | GLP-1 receptor agonists for the treatment of obesity in children and adolescents: a meta-analysis of randomized controlled trials. | Pediatr Res | 2026 | https://conductscience.org/library/papers/40588554 | PubMed |
| 7 | 25036533 | Liraglutide's safety, tolerability, pharmacokinetics, and pharmacodynamics in pediatric type 2 diabetes: a randomized, double-blind, placebo-controlled trial. | Diabetes Technol Ther | 2014 | https://conductscience.org/library/papers/25036533 | PubMed |
| 8 | 33984333 | Safety and Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity: A Meta-Analysis. | J Pediatr | 2021 | https://conductscience.org/library/papers/33984333 | PubMed |
| 9 | 35900132 | Addressing adolescent substance use with a public health prevention framework: the case for harm reduction. | Ann Med | 2022 | https://conductscience.org/library/papers/35900132 | PubMed |
| 10 | 39044306 | Glucagon-like peptide-1 receptor agonists in adolescents with overweight or obesity with or without type 2 diabetes multimorbidity-a systematic review and network meta-analysis. | Diabetes Obes Metab | 2024 | https://conductscience.org/library/papers/39044306 | PubMed |
| 11 | 40450457 | Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. | Am J Clin Nutr | 2025 | https://conductscience.org/library/papers/40450457 | PubMed |
| 12 | 32753461 | Obesity in adults: a clinical practice guideline. | CMAJ | 2020 | https://conductscience.org/library/papers/32753461 | PubMed |
| 13 | 36398631 | Expanding the Role of Bioethics in Translational Science. | J Law Med Ethics | 2022 | https://conductscience.org/library/papers/36398631 | PubMed |
| 14 | 36322838 | Once-Weekly Semaglutide in Adolescents with Obesity. | N Engl J Med | 2022 | https://conductscience.org/library/papers/36322838 | PubMed |
| 15 | 38663923 | Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information Services. | BMJ Open | 2024 | https://conductscience.org/library/papers/38663923 | PubMed |
| 16 | 33963681 | Liraglutide pharmacokinetics and exposure-response in adolescents with obesity. | Pediatr Obes | 2021 | https://conductscience.org/library/papers/33963681 | PubMed |
| 17 | 32062862 | A 6-month randomized, double-blind, placebo-controlled trial of weekly exenatide in adolescents with obesity. | Pediatr Obes | 2020 | https://conductscience.org/library/papers/32062862 | PubMed |
| 18 | 37213102 | Efficacy and Safety of Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist Danuglipron for Glycemic Control Among Patients With Type 2 Diabetes: A Randomized Clinical Trial. | JAMA Netw Open | 2023 | https://conductscience.org/library/papers/37213102 | PubMed |
| 19 | 32471767 | Counterfeit drugs: A major issue for vulnerable citizens throughout the world and in the United States. | J Am Pharm Assoc (2003) | 2021 | https://conductscience.org/library/papers/32471767 | PubMed |
| 20 | 40181228 | How do glucagon-like Peptide-1 receptor agonists affect measures of muscle mass in individuals with, and without, type 2 diabetes: A systematic review and meta-analysis. | Obes Rev | 2025 | https://conductscience.org/library/papers/40181228 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42733817 | Specialty-based variation in glucagon-like Peptide-1 receptor agonist prescribing practices for adolescent obesity in Saudi Arabia. | Obes Pillars | 2026 | https://conductscience.org/library/papers/42733817 | PubMed |
| 42625929 | Current and forthcoming pharmacotherapies for adolescent obesity: Evidence-based review. | World J Clin Pediatr | 2026 | https://conductscience.org/library/papers/42625929 | PubMed |
| 42514386 | Understanding Obesity as a Multisystem Disease: Advancing Research, Redefining Diagnostic Criteria, and Establishing Modern Therapeutic Approaches. | Nutrients | 2026 | https://conductscience.org/library/papers/42514386 | PubMed |
| 42464044 | Bridging the Gaps in Paediatric Obesity Pharmacotherapy. | Diabetes Obes Metab | 2026 | https://conductscience.org/library/papers/42464044 | PubMed |
| 42194134 | Reply to Improda, N.; Ballarin, G. Body Composition in Paediatric GLP-1 Receptor Agonist Therapy. Comment on "Zaitoon et al. Beyond Weight Loss: Optimizing GLP-1 Receptor Agonist Use in Children. Children 2025, 12, 1427". | Children (Basel) | 2026 | https://conductscience.org/library/papers/42194134 | PubMed |
| 42194133 | Body Composition in Paediatric GLP-1 Receptor Agonist Therapy. Comment on Zaitoon et al. Beyond Weight Loss: Optimizing GLP-1 Receptor Agonist Use in Children. Children 2025, 12, 1427. | Children (Basel) | 2026 | https://conductscience.org/library/papers/42194133 | PubMed |
| 42117035 | Oral Nutritional Supplements and Body Composition Outcomes Among GLP-1 Receptor Agonist Users: Real-World Evidence. | Diabetes Metab Syndr Obes | 2026 | https://conductscience.org/library/papers/42117035 | PubMed |
| 41798193 | Glucagon-like peptide-1 agonists in children with obesity and type 2 diabetes. an umbrella review. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/41798193 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GLP1R | 2740 | PubTator's text mining | https://conductscience.org/library/genes/2740 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41300545
GET https://conductscience.org/api/papers/v1/41300545/references?page=2